Ben Wolf will speak on the “Future of Vaccine Development – Will Restrictions Lead to Off Label Use?” panel at the NYSBA Food, Drug & Cosmetic Law Section 2026 Annual Meeting. He will discuss how diverging federal and state vaccine policies—and conflicting ACIP and FDA recommendations—are creating uncertainty around access, administration, and the potential rise of off label vaccination. The panel will examine how these policy tensions may shape future vaccine availability and regulatory strategy.
For more information, click here.